{"id":162629,"date":"2022-08-26T20:52:21","date_gmt":"2022-08-26T15:22:21","guid":{"rendered":"https:\/\/pharmeasy.in\/blog\/?p=162629"},"modified":"2026-07-24T13:20:51","modified_gmt":"2026-07-24T13:20:51","slug":"why-are-generic-medicines-less-expensive","status":"publish","type":"post","link":"https:\/\/pharmeasy.in\/blog\/why-are-generic-medicines-less-expensive\/","title":{"rendered":"Why Are Generic Medicines Less Expensive?"},"content":{"rendered":"\n\n<\/head>

Table of Contents<\/p>\nToggle<\/span>

Introduction<\/a><\/li>
What Is Bioequivalence?<\/a><\/li>
Reasons Why Non-Generic Medication Costs Are Higher Than Generic Medication Prices<\/a><\/li>
How Do Generic Medicines Help Reduce Costs?<\/a><\/li>
Who Regulates Generic Medicines in India?<\/a><\/li>
How to Switch to Generic Medicines?<\/a><\/li>
Conclusion<\/a><\/li>
Frequently Asked Questions (FAQs)<\/a><\/li>
References<\/a><\/li><\/ul><\/nav><\/div>\n \n <\/span>\n $\"Join$ \n <\/a>\n
<\/span>Introduction<\/strong><\/span><\/h2>\n\n\n\nThe pharmaceutical industry is an essential component of health care systems worldwide. It is based mainly on scientific research and the development of medicines for various diseases and disorders. Manufacturing medicines requires substantial investment in research, development, testing, regulatory approval, and production. A newly developed branded (non-generic) medicine) is patent-protected for a certain period of time. The pharmaceutical company that holds the patent and regulatory approval is allowed to manufacture and market the medicine during this time and can recover its investment in research and development. The patent protection prohibits other companies from making and selling copies of the same medicine.
After the patent expires, other manufacturers can produce generic medicines. Generic medicines contain the same active ingredient, strength, dosage form, and intended use as the branded medicine, while meeting the same regulatory standards for quality, safety, and effectiveness 1<\/a><\/sup>. Because generic manufacturers do not have to bear the original costs of drug discovery and development, generic medicines are usually available at significantly lower prices. Let us look at the factors responsible for the high cost of branded (non-generic) medicines<\/p>\n\n\n\n
<\/p>\n\n\n\n
<\/span>What Is Bioequivalence?<\/strong><\/span><\/h2>\n\n\n\nBioequivalence means that a generic medicine delivers the same active ingredient into the bloodstream at a similar rate and to a similar extent as its branded counterpart 5<\/a>,3<\/a><\/sup>. This ensures that the medicine produces a comparable clinical effect when used as directed.<\/p>
<\/div>